Literature DB >> 28231909

An Algorithm for the Use of Embolic Protection During Atherectomy for Femoral Popliteal Lesions.

Prakash Krishnan1, Arthur Tarricone2, K Raman Purushothaman2, Meerarani Purushothaman2, Miguel Vasquez2, Jason Kovacic2, Usman Baber2, Vishal Kapur2, Karthik Gujja2, Annapoorna Kini2, Samin Sharma2.   

Abstract

OBJECTIVES: This study sought to identify an algorithm for the use of distal embolic protection on the basis of angiographic lesion morphology and vascular anatomy for patients undergoing atherectomy for femoropopliteal lesions.
BACKGROUND: Atherectomy has been shown to create more embolic debris than angioplasty alone. Distal embolic protection has been shown to be efficacious in capturing macroemboli; however, no consensus exists for the appropriate lesions to use distal embolic protection during atherectomy.
METHODS: Patients with symptomatic lower extremity peripheral artery disease treated with atherectomy and distal embolic protection were evaluated to identify potential predictors of DE. Plaque collected from the SilverHawk nose cone subset was sent to pathology for analysis to evaluate the accuracy of angiography in assessing plaque morphology.
RESULTS: Significant differences were found in lesion length (142.1 ± 62.98 vs. 56.91 ± 41.04; p = 0.0001), low-density lipoprotein (82.3 ± 40.3 vs. 70.9 ± 23.2; p = 0.0006), vessel runoff (1.18 ± 0.9 vs. 1.8 ± 0.9; p = 0.0001), chronic total occlusion (131 vs. 10; p = 0.001), in-stent restenosis (33 vs. 6; p = 0.0081), and calcified lesions (136 vs. 65; p < 0.001). In simple logistic regression analysis lesion length, reference vessel diameter, chronic total occlusion, runoff vessels, and in-stent restenosis were found to be strongly associated with macroemboli. Angiographic assessment of plaque morphology was accurate. Positive predictive value of 92.31, negative predictive value of 95.35, sensitivity of 92.31, and specificity of 95.35 for calcium; positive predictive value of 95.56, negative predictive value of 100, sensitivity of 100, and specificity of 92.31 for atherosclerotic plaque. Thrombus/in-stent restenosis was correctly predicted.
CONCLUSIONS: Chronic total occlusion, in-stent restenosis, thrombotic, calcific lesions >40 mm, and atherosclerotic lesions >140 mm identified by peripheral angiography necessitate concomitant filter use during atherectomy to prevent embolic complications. Copyright Â
© 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherectomy; embolic protection; peripheral artery disease

Mesh:

Year:  2017        PMID: 28231909     DOI: 10.1016/j.jcin.2016.12.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  4 in total

1.  State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?

Authors:  Ramya C Mosarla; Ehrin Armstrong; Yonatan Bitton-Faiwiszewski; Peter A Schneider; Eric A Secemsky
Journal:  J Soc Cardiovasc Angiogr Interv       Date:  2022-08-20

2.  Embolic Protection in Complex Femoropopliteal Interventions: Safety, Efficacy and Predictors of Filter Macroembolization.

Authors:  Michael Czihal; Zeynep Findik; Christoph Bernau; Max Seidensticker; Jens Ricke; Ulrich Hoffmann; Marcus Treitl; Karla-Maria Treitl
Journal:  Cardiovasc Intervent Radiol       Date:  2020-12-06       Impact factor: 2.740

3.  Comparison and Analysis between the NAV6 Embolic Protection Filter and SpiderFX EPD Filter in Superficial Femoral Artery Lesions.

Authors:  Prakash Krishnan; Arthur Tarricone; Allen Gee; Serdar Farhan; Haroon Kamran; Annapoorna Kini; Samin Sharma
Journal:  J Interv Cardiol       Date:  2021-06-01       Impact factor: 2.279

4.  Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease.

Authors:  Jung-Joon Cha; Jae-Hwan Lee; Young-Guk Ko; Jae-Hyung Roh; Yong-Hoon Yoon; Yong-Joon Lee; Seung-Jun Lee; Sung-Jin Hong; Chul-Min Ahn; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal:  Korean Circ J       Date:  2021-10-28       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.